Lifelight, a technology that allows a smartphone or tablet device to measure blood pressure, pulse and breathing rate simply by a patient looking into the device's built-in camera for 40 seconds, has secured a £1.2 million Innovate UK continuity loan to fast-track remote patient monitoring of vital signs.
With COVID-19 accelerating the demand for scalable remote patient monitoring, further Innovate funding will support Lifelight to measure a user’s vital signs from home. Lifelight offers a solution to the user, who needs to look at their smartphone or tablet screen for up to 40 seconds therefore avoiding unnecessary contact for both user/patient and healthcare worker as well as minimising patient distress. Being a 100% non-contact device Lifelight enables patient self-management via one device, often the patient’s own smartphone and cuts down on unnecessary in-surgery or home visits.
Lifelight’s CEO and founder, Laurence Pearce, said: “Providing remote patient monitoring and enabling clinicians to understand how their patients are doing remotely is crucial in a post-pandemic world. Lifelight is at the forefront of this shift and we are delighted to be recognised in this way by Innovate UK.
“This is an exciting and crucial step towards changing the scope of care and outcomes for population health in the UK and beyond, combining remote patient monitoring and AI to make healthcare accessible for all via a standard smartphone or tablet device.”
